Synthetic HLA binding peptide analogues and uses thereof
作者： David A. Scheinberg , Javier Pinilla-Ibarz
DOI:
关键词:
摘要: The present invention provides synthetic peptides comprising at least analogues of a native peptide that specifically bind to HLA A0201 or A0301 molecules on cell characteristic pathophysiologic state, such as cancer cell, in mammal. Also provided are pharmaceutical compositions and immunogenic the analogue segments DNA encoding same. methods using induce heteroclitic immune response treat cancer.
lens.org参考文章(25)
D. Accapezzato, V. Barnaba, G. Alimena, R. Tosi, N. Tanigaki, R. Butler, D. Fruci, R. Nisini, G. Greco, E. Vigneti, E. Montefusco, Two bcr-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes Leukemia. ,vol. 10, pp. 693- 699 ,(1996)
Mie Nieda, Andrew Nicol, Akiko Kikuchi, Koichi Kashiwase, Kerry Taylor, Kenji Suzuki, Kenji Tadokoro, Takeo Juji, Dendritic Cells Stimulate the Expansion of bcr-abl Specific CD8+ T Cells With Cytotoxic Activity Against Leukemic Cells From Patients With Chronic Myeloid Leukemia Blood. ,vol. 91, pp. 977- 983 ,(1998) , 10.1182/BLOOD.V91.3.977
David A. Scheinberg, Alessandro Sette, Monica Bocchia, Oncogene fusion protein peptide vaccines ,(1996)
Howard M. Grey, Alessandro Sette, Jeff Alexander, Rongfang Wang, Grace Shih, Ulrich Zügel, Termination of Peripheral Tolerance to a T Cell Epitope by Heteroclitic Antigen Analogues Journal of Immunology. ,vol. 161, pp. 1705- 1709 ,(1998)
Antonio Scardino, David-Alexandre Gross, Pedro Alves, Joachim L. Schultze, Stéphanie Graff-Dubois, Olivier Faure, Sophie Tourdot, Salem Chouaib, Lee M. Nadler, François A. Lemonnier, Robert H. Vonderheide, Angelo A. Cardoso, Kostas Kosmatopoulos, HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapy. Journal of Immunology. ,vol. 168, pp. 5900- 5906 ,(2002) , 10.4049/JIMMUNOL.168.11.5900
Alexander Gaiger, Martin A. Cheever, Compositions and methods for diagnosis and therapy of malignant mesothelioma ,(2001)
J. Pinilla-Ibarz, K. Cathcart, T. Korontsvit, S. Soignet, M. Bocchia, J. Caggiano, L. Lai, J. Jimenez, J. Kolitz, D. A. Scheinberg, Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses Blood. ,vol. 95, pp. 1781- 1787 ,(2000) , 10.1182/BLOOD.V95.5.1781.005K46_1781_1787
John G. Gribben, Joachim L. Schultze, Sabine Harig, Robert H. Vonderheide, Angela M. Krackhardt, Andreas Trojan, Rolf A. Stahel, Mathias Witzens, Generation of cytotoxic T lymphocytes against native and altered peptides of human leukocyte antigen-A*0201 restricted epitopes from the human epithelial cell adhesion molecule. Cancer Research. ,vol. 61, pp. 4761- 4765 ,(2001)
Maria R. Parkhurst, Yutaka Kawakami, Scott Southwood, Steven A. Rosenberg, Paul F. Robbins, Alessandro Sette, Michael L. Salgaller, Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues. Journal of Immunology. ,vol. 157, pp. 2539- 2548 ,(1996)
P Yotnda, H Firat, F Garcia-Pons, Z Garcia, G Gourru, J P Vernant, F A Lemonnier, V Leblond, P Langlade-Demoyen, Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia. Journal of Clinical Investigation. ,vol. 101, pp. 2290- 2296 ,(1998) , 10.1172/JCI488